6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality
|
|
|
- Avis Dawson
- 8 years ago
- Views:
Transcription
1 6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA Sponsors and Exhibitors Attendee List as of March 15 th Company AbbVie AbbVie Title Senior Director, Clinical and Pharmacovigilance QA Medical Writing QC & Contracts Manager
2 Acceleron Pharma Achillion Pharmaceuticals Inc. ADAMAS Consulting Alexion R&D QA Alexion R&D QA Alkermes, Inc. Alkermes, Inc. AstraZeneca Bayer Healthcare BIMO Auditor and Trainer, LLC BioMarin Biopharma QA and Outsourcing Consultants Biovalorem Boehringer Ingelheim Pharmaceuticals, Inc. Bristol- Myers Squibb Chugai Pharma USA, LLC ClinAudits, LLC Cook Research CryoLife Daiichi Sankyo Co., Ltd. F.Hoffmann - La Roche Ltd Genentech Gilead Sciences Director, Quality Assurance Vice President, Compliance and Quality Assurance Business Development Senior Manager, Development Quality Director, Development Quality Senior CQA Auditor Global Head CQA; GCP & GPvP Regional Clinical Process Manager Senior Global Clinical Auditor Consultant, xfda Associate Director, Development Sciences Quality Principal Managing Partner Senior Associate Director/Principal Auditor, QM- M&R, Quality Management - Medicine & Regulatory Senior Regulatory Compliance Auditor Associate Director, Quality Assurance President Quality Specialist Project Director, Clinical Research Associate Director, Development Oversight Training Manager Clinical Quality Quality Risk Specialist Associate Director, Clinical Compliance
3 Gilead Sciences Grifols Hoffmann- La Roche Limited Incyte Corporation Inovio Pharmaceuticals inventiv Health Clinical Janssen Johnson & Johnson Karyopharm Therapeutics Lexitas Pharma Services, Inc. Merck Merck Metrics Champion Consortium Pharma AG Senior Director, Regulatory Compliance R&D Compliance Audits Manager Manager, Data Acquisition Clinical Data Management Executive Director QA- GCP Director, Clinical Compliance Senior Vice President, Operational Quality Management Associate Director, Global R&D Quality & Compliance Quality Monitoring & Compliance Manager GCP Quality Manager Manager, Clinical Operations and Quality Assurance Associate Director Compliance Director, Clinical Quality and Process Management Co- Founder & President Project Management Liaison, Translational Clinical Oncology Process Control Manager Director, QA Compliance, Inspection & Risk Management Global Program Quality Lead, Pharma Development Clinical Quality Assurance Clinical Quality Expert, Oncology Development QA Process Control Manager Senior Compliance Specialist, Development QA Standards Global Head, Clinical Development Quality Assurance Global Head Pharma Dev. Franchise QA Immunology, Dermatology & Neuroscience
4 Novo Nordisk A/S Novo Nordisk A/S Otsuka Pharmaceutical Development & Commercialization, Inc. PEARL Network Pfizer Premier Research Purdue Pharma L.P. QD- Quality and Training Solutions, Inc. Sanofi Sarah Cannon Research Institute Sarah Cannon Research Institute Shire Sparta Systems Sparta Systems TESARO, Inc. Teva Senior GCP Advisor Senior GCP Advisor Associate Director, Clinical Quality Management Senior Clinical Research Associate Associate Director, Portfolio Quality & Risk Management Principal QA Auditor Director, Contracted Consulting Services QA Auditor Vice President, Global Quality Assurance Director, R&D Quality Assurance: GLP/GCP/Support President & CEO Senior Director, Knowledge Management GxP Global Auditor Manager, Clinical Quality Assurance Senior Director, Global Quality and Education Head of Clinical QA & Compliance Programs, R&D Quality Assurance & Compliance Director, Solutions Consulting Business Development Manager, Clinical Operations Global Clinical QA Auditor
5 TransTech Pharma LLC Trevena, Inc. Triligent International Vertex Pharmaceuticals, Inc. VirtualScopics, Inc. VirtualScopics, Inc. World Courier Zigzag Associates Ltd. Director, Quality Assurance Vice President, Clinical Operations CEO Director, PV Quality Compliance Management Quality Specialist Manager, QA & Validation Director, Business Development Managing Director, Global Client Services
Proactive GCP Compliance
6 TH ANNUAL Proactive GCP Compliance Effective Risk-Based Approaches for Optimizing Clinical Quality MARCH 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA FEATURED SESSIONS REPONDING
CHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
Clinical trial research agreement Agreed schedule 4 or 7 clause amendments
Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Medicines Australia and Medical Technology Association of Australia templates The sponsors in the table have agreed clauses for
Avoca s Quality Metrics Consulting Service Offering
Avoca s Quality Metrics Consulting Service Offering Avoca s Quality Metrics Consulting The Challenge Biopharmaceutical companies and CROs struggle in defining how best to utilize quality metrics to optimize
Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct
Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:
In the largest and perhaps the most ambitious collaborative
FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated
e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015
e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 PHARMAPACK 2015 1 Mobile health x2 30 months 100 000 mapps Source: research2guidance, mhealth App Market Report 2013-2017
INCENTIVE COMPENSATION CONFERENCE
Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed
Pharma s Sharp Right Turn on R&D Creating an IT Platform to Fuel Future Growth
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Pharma s Sharp Right Turn on R&D Creating an IT Platform to Fuel Future Growth Leading pharmaceutical companies are evaluating
Rx-360 An International Pharmaceutical Supply Chain Consortium
Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)
Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015
Brochure More information from http://www.researchandmarkets.com/reports/3398017/ Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Description: Small-Cell Lung Cancer Global Clinical Trials
ROOT CAUSE ANALYSIS. Prevent Non-Compliance and Achieve Successful Root Cause Analyses and CAPA Systems Implementation from Clinical to Post-Market
5th SIGNAL DETECTION, ROOT CAUSE ANALYSIS & January 22-23, 2015 Key Bridge Marriott Arlington, VA Prevent Non-Compliance and Achieve Successful Root Cause Analyses and CAPA Systems Implementation from
Digital Leaders Deal With a Range of Organizational Challenges
May 22, 2014 OVERCOMING OBSTACLES TO DIGITAL TRANSFORMATION SUCCESS IN THE PHARMACEUTICAL INDUSTRY Digital Leaders Deal With a Range of Organizational Challenges by Tim van Tongeren with Dennis van Rooij
ehealthinsight Series: Online Patient Recruitment Strategies
A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES by Dennis van Rooij with Tim van Tongeren EXECUTIVE SUMMARY More than half of pharma marketers don t or can t leverage
Bridging Clinical Trial Innovation and Quality
May 13-14, 2015 (Preliminary Agenda as of April 3, 2015) Bridging Clinical Trial Innovation and Quality The Westin Princeton at Forrestal Village 201 Village Boulevard Princeton, NJ 08540 Confirmed Speakers
Annual Press Conference 2012. Business Year 2011
Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation
Biopharmaceutical Raw Materials throughout the Product Lifecycle. Biosimilars and Biobetters Development & Production. www.ibclifesciences.
Monday Tuesday Programming: Wednesday Friday Programming: IBC s 18th International Process Validation, Monitoring & Control Supply Chain Management for Biopharmaceuticals Cold Chain Logistics and Distribution
Clinical Trials Inspection Readiness
3 rd Clinical Trials Inspection Readiness Summit August 12-13, 2014 Sonesta Hotel Philadelphia Philadelphia, PA Top Reasons to Attend Only conference in the industry that is exclusively GCP-focused rather
The 2015 Avoca Report. Clinical Development Innovation. Sponsor and Provider Views on Innovation in Outsourced Clinical Development
The 2015 Avoca Report Clinical Development Innovation Sponsor and Provider Views on Innovation in Outsourced Clinical Development Contents Section Slides Research Overview 3-5 Respondent Demographics 6-9
Main Conference Agenda
Sponsored by: (Co-located with Bioequivalence: Intersection between Science & Regulatory Conference) Main Conference Agenda Day One Wednesday, November 5 th, 2014 7:30 Registration Opens & Continental
PARTIAL DELEGATE LIST (as of Jan. 15, 2013) Electronic Data in Clinical Trials /Integration and Leveraging Clinical Trial Operations Data Conferences
PARTIAL DELEGATE LIST (as of Jan. 15, 2013) Electronic Data in Clinical Trials /Integration and Leveraging Clinical Trial Operations Data Conferences February 5-7, 2013 - Hyatt Regency Miami Miami, FL
Later-Stage Development: Ensuring Compliance During. for a Competitive Advantage Webinar Series
Part II: Later-Stage Development: Ensuring Compliance During Clinical i l Trials Process Driven Compliance for a Competitive Advantage Webinar Series 29 September 2010 Process Driven Compliance Webinar
To know more about Pharmacovigilance and Clinical Trials Data Management
To know more about Pharmacovigilance and Clinical Trials Data Management 1. What is Pharmacovigilance? Pharmacovigilance (PV) is the pharmacological science related to the detection, assessment, understanding
Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)
A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors
Biopharmaceutical Raw Materials throughout the Product Lifecycle
February 27 March 2, 2012 Hilton San Diego Bayfront San Diego, CA Monday Tuesday Programming: IBC s 17th International Process & Analytical Assay Validation IBC s 8th International Outsourcing Manufacturing
Global Peptide Therapeutics Market 2014-2018
Brochure More information from http://www.researchandmarkets.com/reports/3022209/ Global Peptide Therapeutics Market 2014-2018 Description: About Peptide Therapeutics Peptides are amino acids sequences
Jobbetegnelser for det nuværende job i branchen
Jobbetegnelser for det nuværende job i branchen Administrerende direktør (CEO) Academic, Project manage Advanced Business Analyst Advanced Business Analyst, IT&CD, IT System Management Analytical Service
Pharmaceutical industry
8 th March 2016 Pharmaceutical industry 2015 Global ranking strategy decisive The annual company reporting season is always an exciting period. It is an ideal time to update our industry statistics and
Pharma working capital performance highly variable
April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the
Clinical Trial Supply Europe 2016 Barcelona, 2 nd & 3 rd March 2016 2016 SPEAKERS INCLUDE
Clinical Trial Supply Europe 2016 Barcelona, 2 nd & 3 rd March 2016 2016 SPEAKERS INCLUDE Jan-Pieter Kappelle, Senior Director, Global Clinical Trial Supplies, UCB Didier Basseras, Vice President, Clinical
THE VIRAL HEPATITIS CONGRESS 2015. 10 12 September 2015, Kap Europa, Frankfurt, Germany THE VIRAL HEPATITIS CONGRESS. Scientific Programme
THE VIRAL HEPATITIS CONGRESS THE VIRAL HEPATITIS CONGRESS 2015 10 12 September 2015, Kap Europa, Frankfurt, Germany Scientific Programme PRE-CONGRESS WORKSHOP SPONSOR ACHILLION Achillion is seeking to
Commercial Insight Osteoarthritis and Rheumatoid Arthritis
A Datamonitor In-Depth Analysis Commercial Insight Osteoarthritis and Rheumatoid Arthritis New Growth In A Mature Market Published: Jul-03 Product Code: DMHC1891 Why buy this analysis? Target current and
KEEPING CLINICAL TRIALS IN AUSTRALIA
OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought
PPRS 2014 analysis of growth in spend of branded medicines. DH Leading the nation s health and care
PPRS 2014 analysis of growth in spend of branded medicines March 2015 Executive Summary IMS Health data shows growth in spend in 2014 (compared to 2013) of 8.2% on branded medicines. This is higher than
Pharmaceutical Marketing Disclosures
Pharmaceutical Marketing Disclosures July 1, 2007 June 30, 2008 Report of Vermont Attorney General William H. Sorrell April 2009 Prepared by staff of the Vermont Attorney General s Office: Wendy Morgan,
Stakeholder Perspectives: Mild Cognitive Impairment and Dementia
A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?
THE BIOTECH & PHARMACEUTICAL INDUSTRY
THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues
Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595
Transparency Market Research Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample Published Date:
Clinical Trials OUTSOURCING & DEVELOPMENT
Clinical Trials OUTSOURCING & DEVELOPMENT 2-3 rd December Singapore A clinical partnering event for outsourcing and development professionals and service providers in late phase clinical trials DRAFT AGENDA
VAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY
VAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY SUMMARY Healthcare Summary Personal health care expenditures projected to grow 26% in the next 4 years Hospital care sector comprises
Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
Pharmaceutical Quality & Clinical Research Quality: The Interaction
4 th Jerusalem Conference: Quality by Design (QbD)) & Pharma Sciences, May 20-22, 2014 The Edmund Safra Campus, The Hebrew University of Jerusalem Pharmaceutical Quality & Clinical Research Quality: The
BOLT Hem/Onc Thought Leader Panel #38 Cancer Immunotherapy 2014-05
Syndicated Thought Leader Insight Healthcare & Pharmaceutical Research Cancer Immunotherapy Melanoma, Non- Small Cell Lung Cancer, Renal Cell Carcinoma Thought Leader Panel #38 2014-05 Therapeutic Area:
Acknowledgements. We thank these organizations and individuals for their unrestricted support.
Power to the People Presented by Dawn Richards, PhD, Person with Rheumatoid Arthritis Arthritis Consumer Experts Advisory Board Member Canadian Arthritis Patient Alliance Vice President Acknowledgements
PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14
PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14 March 5-6, 2014 Princeton, NJ The Nassau Inn Identify, Prioritize and Solve Key Operational Challenges that Shape the Customer Experience in Pharma GOLD SPONSORS
Committed to innovation and growth
Committed to innovation and growth Alan Hippe, CFO Roche Group London, September 2012 This presentation contains certain forward-looking statements. These forward-looking statements may be identified by
Susmita Gupta, Sr. CDM Project Manager, Endo Pharmaceuticals, USA
March 4-5 2013, Morristown, NJ, USA www.clinical-trials-events.com/chinausa.html www.clinical-trials-events.com/asiausa.html The 5th China and Asia Clinical Trials Outsourcing Congress Asia has the fastest
Serialization Technology - Seidenader: Integral Solution Provider
Serialization Technology - Seidenader: Integral Solution Provider Sindusfarma August, 28th 2013 Dr. Stefan Loelkes Agenda 1 2 Your challenge Company overview 3 4 Integral solution provider Products 2 Your
Global Pharmaceuticals Marketing Channel Reference EDITION
Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry
DIA 2016. 52 ND Annual Meeting. Exhibitor Prospectus
DIA 2016 52 ND Annual Meeting MEETING DATES: JUNE 26-30, 2016 EXHIBIT DATES: JUNE 27-29, 2016 Pennsylvania Convention Center Philadelphia, PA Exhibitor Prospectus Join the who s who in the life sciences
4 th Annual Clinical Development and Trials Asia Congress. 5 th Annual Pharma R&D World Asia Congress
Oxford Global Medical Conferences Imaging technologies are proud to present the 4 th Annual Clinical Development and Trials Asia Congress and Implementing biomarkers in co-located early phase Pharma clinical
Management, Supply and Quality Assurance of Clinical Trials
Speakers Brigitte Bastyns Johnson&Johnson Rita Hattemer- Apostel Verdandi AG Andreas Jungk Lawfirm Jungk Helena Lindberg GCP Inspector, Swedish Medical Products Agency Dr Claudio Lorck AbbVie Dr Andreas
Biotie Therapies Corp. 4.3.2014
1 Biotie Therapies Corp. Corporate Governance Statement 2013 2 CONTENTS 1. Corporate Governance Statement 2. Board of Directors 2.1. Board composition 2.2. The operation of the Board of Directors 2.3.
Pharma working capital leaves room for improvement
October 2012 Pharma working capital leaves room for improvement 50.7 Billion in Excess Working Capital Ten years ago it was not unusual to be asked why working capital mattered to a pharmaceutical company.
Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries
Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be
e-clinical Trials vibpharma register now: tel: +44 (0)20 7753 4268 Fax: +44 (0) 20 7915 9773
vibpharma e-clinical Trials tuesday 18 and Wednesday 19 May 2010, Munich, Germany Maximising clinical trial supply efficiency by utilising advanced e-tools and systems Choose from a selection of roundtable
EvaluatePharma World Preview 2015, Outlook to 2020
EvaluatePharma World Preview 2015, Outlook to 2020 8th Edition June 2015 Welcome to the EvaluatePharma World Preview 2015, Outlook to 2020 The eighth edition of EvaluatePharma s World Preview brings together
Medical Writing Takes Off in India
Visit http://store.centerwatch.com to learn more about State of the Clinical Trials Industry 2008 Special Article Reprint For the latest news and views on the clinical trials industry visit ClinicalTrialsToday.com
Campbell Alliance. Press Kit Materials
Campbell Alliance Press Kit Materials Raleigh, N.C. Parsippany, N.J. Woodland Hills, Calif. South San Francisco Chicago New York City TABLE OF CONTENTS Document Page # About Campbell Alliance 3 Company
Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants
Publishing Staff Senior Vice President of Operations and Clinical Affairs Jeff D. Prescott, PharmD, RPh Senior Clinical Projects Manager Ida Delmendo Clinical Projects Manager Tara Petersen Project Director
Quality in pharmacovigilance systems
Quality in pharmacovigilance systems June 20 th, 2014 Lisa Stagi, Medical Compliance Leader Roche Spa Quality systems in pharmacovigilance: legal requirements Regulation 1235/2010 e Directive 2010/84 Legal
Building innovative drug discovery alliances. Profitable. Growth Go
Building innovative drug discovery alliances Innovation n & Profitable Growth Go Evotec AG, H1 Presentation, 8 th August 2012 Forward-looking statements Information set forth in this presentation contains
American College of Gastroenterology Educational Affairs Committee 2015 Conflicts of Interest
American College of Gastroenterology Educational Affairs Committee 2015 Conflicts of Interest The American College of Gastroenterology (ACG) is accredited by the Accreditation Council for Continuing Medical
The Landscape of Clinical Trial Data Sharing Initiatives
2 T R I A L D ES I G N & R EG I S TRAT I O N P A R T I C I P ANT EN R O L L M EN T M E T A D ATA R EG I STRAT I O N EL EM EN TS DATA S H A R I N G P L A N I N D I V I D U A L P A R T I C I PA NT D A T
BANKING - ASSET MANAGEMENT AND INVESTMENT
BANKING - ASSET MANAGEMENT AND INVESTMENT INVESTMENT BANKING / PRIVATE EQUITY - ORIGINATION ROLES Analyst 20,000 15,000 35,000 Associate 35,000 25,000 65,000 Vice President 55,000 35,000 90,000 Director
Invesco Funds Series 3 Interim Report (Unaudited) For the six months ended 31 May 2015
Invesco s Series 3 Interim Report (Unaudited) For the six months ended 31 May 2015 Health Care 01 Investment Policy and Description of the Series 02 Investment Adviser s Report on behalf of the Manager
Rx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency
Rx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency www.rx-360.org www.rx-360.org Presenter: Rob Welsh, VWR International, LLC VP Category Management
Digital Apps Portals Mobile Advertising Opportunities 2014
Digital Apps Portals Mobile Advertising Opportunities 2014 bmj.com/company Contents Contents 2 Targeting doctors and healthcare professionals 3 bmj.com 4 Email alerts 6 ipad app 7 The BMJ specialty portals
The Clinical Research Association of Canada & the Canadian Chapter of ACRP Presents: NEW MODELS & BEST PRACTICES IN CLINICAL RESEARCH
The Clinical Research Association of Canada & the Canadian Chapter of ACRP Presents: NEW MODELS & BEST PRACTICES IN CLINICAL RESEARCH Thursday, May 29 th, 2014 Novotel Montreal Airport Hotel 2599 boul.
SPECIAL REPORT: OUTSOURCING HEAD IN THE CLOUDS OVER E-TMF DATA MINING FOR SERIALISATION: NO TIME TO DELAY
Volume 85 Number 10 October 2014 Development Formulation Processing Outsourcing Packaging Equipment Ingredients Regulatory The new platform excipient for tablets, sachets and more first rate filler-binder
Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota 55403 612.202.6805 shaecker@celltherapygroup.com
Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota 55403 612.202.6805 shaecker@celltherapygroup.com PROFILE Successful Senior Executive, skilled in Corporate Development including Business
Biometrics: Clinical Trials and Beyond
Biometrics: Clinical Trials and Beyond Statistics, Programming, and Data Management in Research, Development, and Regulatory Submissions. For all, Not Just Statisticians! Keynote Presentations Sue-Jane
Sharing Industry Clinical Trial Data: Improving Public Health While Maintaining the Oversight Relationship Between Regulator and Sponsor
Sharing Industry Clinical Trial Data: Improving Public Health While Maintaining the Oversight Relationship Between Regulator and Sponsor Steven Snapinn SCT/QSPI/FDA Workshop Innovations in the Science
The Gold Standard for Processing and Packaging
PACK EXPO Las Vegas Exhibitor Prospectus The Gold Standard for Processing and Packaging 2 O YEARS co-located with: packexpolasvegas.com/exhibit2015 A Reliable Source of Excellence When you exhibit at PACK
Emerging Medtech Markets Vivo Ventures Time Arrives As All Eyes Look To China
Special Reprint Elsevier Business Intelligence www.elsevierbi.com Emerging Pharma Markets Ironwood Adds A China Wrinkle To Regional Deal Strategy By Wendy Diller Emerging Medtech Markets Vivo Ventures
Brochure More information from http://www.researchandmarkets.com/reports/3292678/
Brochure More information from http://www.researchandmarkets.com/reports/3292678/ Asia Pacific (India, China, Australia, South Korea & Others) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long
Manufacturer of drug substance
Original s and Biosimilars (marketing authorizations in the EU) Date: January 2016 1) Somatropin s ORIGINAL PRODUCTS: Authorization Genentech Genotropin Somatropin Pharmacia/ Pfizer E. coli Humatrope Somatropin
Salary Survey 2014. Domestic, International Salary Survey and Country Cost Analysis
Salary Survey 2014 Domestic, International Salary Survey and Country Cost Analysis Disclaimer: This salary guides contained herewith have been constructed to represent average salaries across a range of
Industry NHS data sharing for collaborative product development
Industry NHS data sharing for collaborative product development Changing strategies in clinical evidence gathering: Are randomised, doubleblinded studies to become extinct? The RCT is not extinct, but
The Access to Medicine Index 2014
The Access to Medicine Index 2014 Access to Medicine Index 2014 Access to Medicine Foundation Scheepmakersdijk 5a NL-2011 AS Haarlem The Netherlands On behalf of the Access to Medicine Foundation, Please
2 Day Seminar Assuring Data Integrity in the Life Science industry
2 Day Seminar Assuring Data Integrity in the Life Science industry Location 1: Boston Sep 08 09 Hilton Garden Inn Boston Logan Airport 100 Boardman Street, Boston, MA 02128 Hotel: 617-567- 6789 Location
Quality Agreements: Contractual Commitments by CROs to Deliver High-Quality Work
Vol. 10, No. 11, November 2014 Happy Trials to You Quality Agreements: Contractual Commitments by CROs to Deliver High-Quality Work By Tom McGrady and Susan Callery-D Amico Introduction Regulated companies
2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit
2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit Addressing the most critical issues facing China s pharma & life science sector 10 th & 11 th April, 2014 Shanghai China
Swiss & Global AM HEALTHCARE : UN SECTEUR EN PLEINE SANTE
Picture Swiss & Global AM HEALTHCARE : UN SECTEUR EN PLEINE SANTE The exclusive manager of Julius Baer Funds. A member of the GAM group. Swiss & Global AM HEALTHCARE : UN SECTEUR EN PLEINE SANTE Christophe
APAC CRO Market A deep dive into the trends transforming APAC CRO industry. P86A-52 June 2015
APAC CRO Market A deep dive into the trends transforming APAC CRO industry June 2015 Table of Contents Section Slide Numbers Executive Summary 10 Key Findings 11 Total CRO Market Size By Stages of Clinical
Metastatic Breast Cancer - Pipeline Review, Q1 2011
Brochure More information from http://www.researchandmarkets.com/reports/1524592/ Metastatic Breast Cancer - Pipeline Review, Q1 2011 Description: Metastatic Breast Cancer - Pipeline Review, Q1 2011 Summary
Commercial Perspectives: Multiple Sclerosis
A Datamonitor Report Commercial Perspectives: Multiple Sclerosis How to Find Opportunities in an Unremitting Market Published: Jun-04 Product Code: Providing you with: In-depth profiles of current market-leading
Associate Group Director, Regulatory Intelligence & Policy
Date: 06/24/16 Associate Group Director, Regulatory Intelligence & Policy Job ID: 2974410847 Job Function Project Management Regulatory Affairs Location United States - District of Columbia Washington
The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor
The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality
Life Sciences Outlook. New Jersey 2015
Life Sciences Outlook New Jersey 2015 New Jersey M&A activity in New Jersey has led to the consolidation of surplus real estate holdings and diminished head counts. However, midsized companies are helping
The Access to Medicine Index 2014
The Access to Medicine Index 2014 Access to Medicine Foundation Scheepmakersdijk 5a NL-2011 AS Haarlem The Netherlands On behalf of the Access to Medicine Foundation, Please contact Jayasree K. Iyer, Head
Biotech Opportunities for Start-Up Firms in Japan and Asia
Biotech Opportunities for Start-Up Firms in Japan and Asia - Corporate VC s Perspective - Yoshitaka Yoneyama, Ph.D. President & CEO Astellas Venture Management LLC. April 25, 2006 About Astellas Pharma
The Premier Organization for Strategic Alliance Management Professionals
The Premier Organization for Strategic Alliance Management Professionals Why ASAP? Global Organization Members throughout the US, Canada UK, Europe, and Asia Board of Directors are Senior Executives from
Public Policy & Market Influence
B Public Policy & Market Influence Pharmaceutical companies operate in an environment where low R&D success rates a, the pressure to maintain profits and a fiercely competitive landscape can increase the
2014 Event Sponsors: For more information please contact marketing@oxfodglobalasia.com
Oxford Global Conferences are proud to present the 3 rd Annual Clinical Trials & Outsourcing Asia Congress and 4 th Annual Pharma R&D Asia Congress to be held on the 27 th & 28 th February 2014 in Shanghai,
The Future of Genomic Medicine VII Thursday, March 6 and Friday, March 7, 2014 Scripps Seaside Forum La Jolla, California. Exhibitor Prospectus
The Future of Genomic Medicine VII Thursday, March 6 and Friday, March 7, 2014 Scripps Seaside Forum La Jolla, California Exhibitor Prospectus About the Course The 7th Future of Genomic Medicine conference
From Big Data to Insights
From Big Data to Insights Lino Mari Senior Technical Architect From Big Data to Insights Big Data is revolutionizing analytics, databases and business. There is much buzz around Big Data these days, especially
Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis
Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Paulina Ramirez: Birmingham Business School IRIMA Workshop on the Internationalisation